# Interplay Between Interleukin-6 and Glucagon in the Regulation of Human Amino Acid and Protein Homeostasis

> **NCT06721910** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 26 (actual)

## Conditions studied

- Healthy
- Glucagon Resistance
- Amino Acid Change

## Interventions

- **DRUG:** Tocilizumab
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06721910
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-15
- **Primary completion:** 2025-09-18
- **Final completion:** 2025-09-18
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06721910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06721910, "Interplay Between Interleukin-6 and Glucagon in the Regulation of Human Amino Acid and Protein Homeostasis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06721910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*